Sabato AF - Search Results

1

Role of the informed consent, from mesotherapy to opioid therapy.

Mammucari M, Lazzari M, Maggiori E, Gafforio P, Tufaro G, Baffini S, Maggiori S, Palombo E, de Meo B, Sabato AF; Steering Committee of Italian Society of Mesotherapy (SIM), Italy. Mammucari M, et al. Among authors: sabato af. Eur Rev Med Pharmacol Sci. 2014;18(4):566-74. Eur Rev Med Pharmacol Sci. 2014. PMID: 24615182 Free article.

2

Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy.

Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mammucari M, et al. Among authors: sabato af. Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):682-94. Eur Rev Med Pharmacol Sci. 2011. PMID: 21796873 Review.

3

Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy.

Mammucari M, Gatti A, Maggiori S, Sabato AF. Mammucari M, et al. Among authors: sabato af. Evid Based Complement Alternat Med. 2012;2012:436959. doi: 10.1155/2012/436959. Epub 2012 May 13. Evid Based Complement Alternat Med. 2012. PMID: 22654954 Free PMC article.

4

Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation.

Gatti A, Casali M, Lazzari M, Tufaro G, Gafforio P, Silvestri C, Marcassa C, Sabato AF. Gatti A, et al. Among authors: sabato af. Adv Ther. 2013 Jan;30(1):41-59. doi: 10.1007/s12325-012-0074-0. Epub 2012 Dec 21. Adv Ther. 2013. PMID: 23269562

5

Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis.

Lazzari M, Sabato AF, Caldarulo C, Casali M, Gafforio P, Marcassa C, Leonardis F. Lazzari M, et al. Among authors: sabato af. Curr Med Res Opin. 2014 Apr;30(4):555-64. doi: 10.1185/03007995.2013.866545. Epub 2013 Dec 5. Curr Med Res Opin. 2014. PMID: 24251879

6

Beyond the traditional definition of breakthrough pain: an observational study.

Gatti A, Gentili M, Iorno V, Mammucari M, Tufaro G, Lazzari M, Sabato AF. Gatti A, et al. Among authors: sabato af. Adv Ther. 2013 Mar;30(3):298-305. doi: 10.1007/s12325-013-0013-8. Epub 2013 Feb 25. Adv Ther. 2013. PMID: 23444055

7

Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain.

Gatti A, Sabato E, Di Paolo AR, Mammucari M, Sabato AF. Gatti A, et al. Among authors: sabato af, sabato e. Clin Drug Investig. 2010;30 Suppl 2:3-14. doi: 10.2165/1158414-S0-000000000-00000. Clin Drug Investig. 2010. PMID: 20670044 Review.

8

Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study.

Gatti A, Mammucari M, Sabato E, Masucci L, Sabato AF. Gatti A, et al. Among authors: sabato af, sabato e. Adv Ther. 2011 May;28(5):418-26. doi: 10.1007/s12325-011-0020-6. Epub 2011 Apr 8. Adv Ther. 2011. PMID: 21491171

9

Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study.

Gatti A, Mediati RD, Reale C, Cuomo A, Vellucci R, Russo G, Costantini A, Canneti A, Luzi M, Mammucari M, Sabato AF. Gatti A, et al. Among authors: sabato af. Adv Ther. 2012 May;29(5):464-72. doi: 10.1007/s12325-012-0022-z. Epub 2012 May 21. Adv Ther. 2012. PMID: 22622488

10

Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.

Dauri M, Lazzari M, Casali M, Tufaro G, Sabato E, Sabato AF. Dauri M, et al. Among authors: sabato af. Clin Drug Investig. 2014 May;34(5):309-16. doi: 10.1007/s40261-014-0176-3. Clin Drug Investig. 2014. PMID: 24567278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters